Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE MLV & Co.
Adds Seasoned Former Jefferies Healthcare Analyst
NEW YORK, March 20, 2013 /PRNewswire/ -- MLV & Co. (MLV), an independent full service investment bank focused on capital intensive industries, announced that Dr. Graig Suvannavejh has joined the firm's equity research team as a Senior Healthcare Research Analyst, where he will expand MLV's coverage of the healthcare sector and direct its healthcare research efforts. His addition to MLV further exemplifies the bank's ability to attract professionals who are leaders in their field to the firm's rapidly growing platform.
"We are pleased to welcome Graig to MLV as we continue our strategic build-out as an independent investment bank and institutional broker-dealer with a core focus of servicing corporate and institutional clients in capital intensive industries and raising capital efficiently for participants in these industries," said Patrice McNicoll , CEO and founder of MLV & Co. "Graig is a highly regarded analyst who will infuse value in the coverage of this segment and enhance the breadth of our healthcare expertise. His deep knowledge of the sector, strong relationships, and differentiated research fit perfectly into MLV's core competencies."
Dean Colucci, President of MLV, further commented, "MLV has grown dramatically since its inception in 2010, despite challenging market conditions. Research is an important pillar of this growth, and we are proud that MLV's coverage universe has expanded to a broad range of capital intensive sectors, including life sciences, energy, and real estate. Graig's exceptional analytical skills and strong academic background reaffirm our dedication to covering the healthcare sector. His addition demonstrates our long term commitment to providing exceptional investment ideas to our clients."
Dr. Suvannavejh commented, "I embrace the opportunity to join this talented team of professionals. Together with Dr. George Zavoico, I look forward to further expanding MLV's healthcare research coverage to continue providing value-added insight to our clients, and also raising MLV's profile among life science companies and healthcare-focused institutional investors."
Dr. Suvannavejh has had a long, distinguished career in healthcare equity research that began in 2001. Prior to joining MLV & Co., he was a senior publishing analyst covering specialty pharmaceuticals at Jefferies. He was also a senior publishing analyst covering the biotechnology sector at UBS, where he began his tenure there as an associate analyst on a large cap pharmaceuticals team that consistently ranked among the leaders in the sector, according to Institutional Investor magazine. Prior to UBS, Dr. Suvannavejh was an associate analyst on the large cap pharmaceuticals team at CIBC World Markets. He began his professional career as a healthcare investment banker at JPMorgan. He holds a Ph.D. in Neuroscience from Northwestern University, and an M.S. in Physiology and a B.S. in Biology, both from Georgetown University.
About MLV & Co.
An independent full service investment bank and institutional broker dealer, MLV is focused on providing outstanding service to institutional investors and growing companies in healthcare, real estate, energy, financials, natural resources, and other capital intensive sectors. Since its inception in 2010, MLV has completed more than 150 transactions and raised more than $4 billion of behalf of its clients.
MLV has also been the market leader in ATM transactions since its start up. From January 2010 through December 31, 2012, MLV has been the lead underwriter on 85 ATMs totaling nearly $3 billion, surpassing every other investment bank during this period. Prior to forming MLV & Co, MLV principals had originated approximately 40 ATM transactions and raised over $6 billion in equity capital through at-the-market issuance.
MLV is a member of FINRA and the SIPC.
©2012 PR Newswire. All Rights Reserved.